Global Contraceptives Drugs and Devices Market Research Report 2025(Status and Outlook)
Report Overview
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
This report provides a deep insight into the global Contraceptives Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Contraceptives Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Contraceptives Drugs and Devices market in any manner.
Global Contraceptives Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer
Inc
Bayer AG
Mayer Laboratories
Inc
The Female Health Company
Cooper Surgical
Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru
Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD
Inc
Afaxys
Inc
Mithra Pharmaceuticals
Abbvie
Market Segmentation (by Type)
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segmentation (by Application)
Female
Male
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Contraceptives Drugs and Devices Market
Overview of the regional outlook of the Contraceptives Drugs and Devices Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
This report provides a deep insight into the global Contraceptives Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Contraceptives Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Contraceptives Drugs and Devices market in any manner.
Global Contraceptives Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer
Inc
Bayer AG
Mayer Laboratories
Inc
The Female Health Company
Cooper Surgical
Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru
Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD
Inc
Afaxys
Inc
Mithra Pharmaceuticals
Abbvie
Market Segmentation (by Type)
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segmentation (by Application)
Female
Male
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Contraceptives Drugs and Devices Market
Overview of the regional outlook of the Contraceptives Drugs and Devices Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Contraceptives Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptives Drugs and Devices Segment by Type
1.2.2 Contraceptives Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Contraceptives Drugs and Devices Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptives Drugs and Devices Product Life Cycle
3.3 Global Contraceptives Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptives Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptives Drugs and Devices Market Competitive Situation and Trends
3.8.1 Contraceptives Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptives Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptives Drugs and Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptives Drugs and Devices Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Contraceptives Drugs and Devices Market Size Market Share by Type (2020-2025)
6.4 Global Contraceptives Drugs and Devices Price by Type (2020-2025)
7 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Contraceptives Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVES DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Region
8.2 Global Contraceptives Drugs and Devices Market Size by Region
8.2.1 Global Contraceptives Drugs and Devices Market Size by Region
8.2.2 Global Contraceptives Drugs and Devices Market Size Market Share by Region
8.3 North America
8.3.1 North America Contraceptives Drugs and Devices Sales by Country
8.3.2 North America Contraceptives Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptives Drugs and Devices Sales by Country
8.4.2 Europe Contraceptives Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptives Drugs and Devices Sales by Region
8.5.2 Asia Pacific Contraceptives Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptives Drugs and Devices Sales by Country
8.6.2 South America Contraceptives Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Contraceptives Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVES DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives Drugs and Devices by Region(2020-2025)
9.2 Global Contraceptives Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptives Drugs and Devices Production
9.4.1 North America Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptives Drugs and Devices Production
9.5.1 Europe Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptives Drugs and Devices Production (2020-2025)
9.6.1 Japan Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptives Drugs and Devices Production (2020-2025)
9.7.1 China Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Basic Information
10.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
10.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Market Performance
10.1.4 Teva Pharmaceutical Industries Ltd Business Overview
10.1.5 Teva Pharmaceutical Industries Ltd SWOT Analysis
10.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.2 Church and Dwight Co. Inc
10.2.1 Church and Dwight Co. Inc Basic Information
10.2.2 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
10.2.3 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.2.4 Church and Dwight Co. Inc Business Overview
10.2.5 Church and Dwight Co. Inc SWOT Analysis
10.2.6 Church and Dwight Co. Inc Recent Developments
10.3 Reckitt Benckiser Plc
10.3.1 Reckitt Benckiser Plc Basic Information
10.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
10.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Market Performance
10.3.4 Reckitt Benckiser Plc Business Overview
10.3.5 Reckitt Benckiser Plc SWOT Analysis
10.3.6 Reckitt Benckiser Plc Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Contraceptives Drugs and Devices Product Overview
10.4.3 Pfizer Contraceptives Drugs and Devices Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Inc
10.5.1 Inc Basic Information
10.5.2 Inc Contraceptives Drugs and Devices Product Overview
10.5.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Bayer AG
10.6.1 Bayer AG Basic Information
10.6.2 Bayer AG Contraceptives Drugs and Devices Product Overview
10.6.3 Bayer AG Contraceptives Drugs and Devices Product Market Performance
10.6.4 Bayer AG Business Overview
10.6.5 Bayer AG Recent Developments
10.7 Mayer Laboratories
10.7.1 Mayer Laboratories Basic Information
10.7.2 Mayer Laboratories Contraceptives Drugs and Devices Product Overview
10.7.3 Mayer Laboratories Contraceptives Drugs and Devices Product Market Performance
10.7.4 Mayer Laboratories Business Overview
10.7.5 Mayer Laboratories Recent Developments
10.8 Inc
10.8.1 Inc Basic Information
10.8.2 Inc Contraceptives Drugs and Devices Product Overview
10.8.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.8.4 Inc Business Overview
10.8.5 Inc Recent Developments
10.9 The Female Health Company
10.9.1 The Female Health Company Basic Information
10.9.2 The Female Health Company Contraceptives Drugs and Devices Product Overview
10.9.3 The Female Health Company Contraceptives Drugs and Devices Product Market Performance
10.9.4 The Female Health Company Business Overview
10.9.5 The Female Health Company Recent Developments
10.10 Cooper Surgical
10.10.1 Cooper Surgical Basic Information
10.10.2 Cooper Surgical Contraceptives Drugs and Devices Product Overview
10.10.3 Cooper Surgical Contraceptives Drugs and Devices Product Market Performance
10.10.4 Cooper Surgical Business Overview
10.10.5 Cooper Surgical Recent Developments
10.11 Inc
10.11.1 Inc Basic Information
10.11.2 Inc Contraceptives Drugs and Devices Product Overview
10.11.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.11.4 Inc Business Overview
10.11.5 Inc Recent Developments
10.12 Allergan plc
10.12.1 Allergan plc Basic Information
10.12.2 Allergan plc Contraceptives Drugs and Devices Product Overview
10.12.3 Allergan plc Contraceptives Drugs and Devices Product Market Performance
10.12.4 Allergan plc Business Overview
10.12.5 Allergan plc Recent Developments
10.13 Cipla Limited
10.13.1 Cipla Limited Basic Information
10.13.2 Cipla Limited Contraceptives Drugs and Devices Product Overview
10.13.3 Cipla Limited Contraceptives Drugs and Devices Product Market Performance
10.13.4 Cipla Limited Business Overview
10.13.5 Cipla Limited Recent Developments
10.14 Merck and Co. Inc
10.14.1 Merck and Co. Inc Basic Information
10.14.2 Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
10.14.3 Merck and Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.14.4 Merck and Co. Inc Business Overview
10.14.5 Merck and Co. Inc Recent Developments
10.15 Veru
10.15.1 Veru Basic Information
10.15.2 Veru Contraceptives Drugs and Devices Product Overview
10.15.3 Veru Contraceptives Drugs and Devices Product Market Performance
10.15.4 Veru Business Overview
10.15.5 Veru Recent Developments
10.16 Inc
10.16.1 Inc Basic Information
10.16.2 Inc Contraceptives Drugs and Devices Product Overview
10.16.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.16.4 Inc Business Overview
10.16.5 Inc Recent Developments
10.17 Organon Group of Companies
10.17.1 Organon Group of Companies Basic Information
10.17.2 Organon Group of Companies Contraceptives Drugs and Devices Product Overview
10.17.3 Organon Group of Companies Contraceptives Drugs and Devices Product Market Performance
10.17.4 Organon Group of Companies Business Overview
10.17.5 Organon Group of Companies Recent Developments
10.18 Agile Therapeutics
10.18.1 Agile Therapeutics Basic Information
10.18.2 Agile Therapeutics Contraceptives Drugs and Devices Product Overview
10.18.3 Agile Therapeutics Contraceptives Drugs and Devices Product Market Performance
10.18.4 Agile Therapeutics Business Overview
10.18.5 Agile Therapeutics Recent Developments
10.19 TherapeuticsmMD
10.19.1 TherapeuticsmMD Basic Information
10.19.2 TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
10.19.3 TherapeuticsmMD Contraceptives Drugs and Devices Product Market Performance
10.19.4 TherapeuticsmMD Business Overview
10.19.5 TherapeuticsmMD Recent Developments
10.20 Inc
10.20.1 Inc Basic Information
10.20.2 Inc Contraceptives Drugs and Devices Product Overview
10.20.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.20.4 Inc Business Overview
10.20.5 Inc Recent Developments
10.21 Afaxys
10.21.1 Afaxys Basic Information
10.21.2 Afaxys Contraceptives Drugs and Devices Product Overview
10.21.3 Afaxys Contraceptives Drugs and Devices Product Market Performance
10.21.4 Afaxys Business Overview
10.21.5 Afaxys Recent Developments
10.22 Inc
10.22.1 Inc Basic Information
10.22.2 Inc Contraceptives Drugs and Devices Product Overview
10.22.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.22.4 Inc Business Overview
10.22.5 Inc Recent Developments
10.23 Mithra Pharmaceuticals
10.23.1 Mithra Pharmaceuticals Basic Information
10.23.2 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
10.23.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Market Performance
10.23.4 Mithra Pharmaceuticals Business Overview
10.23.5 Mithra Pharmaceuticals Recent Developments
10.24 Abbvie
10.24.1 Abbvie Basic Information
10.24.2 Abbvie Contraceptives Drugs and Devices Product Overview
10.24.3 Abbvie Contraceptives Drugs and Devices Product Market Performance
10.24.4 Abbvie Business Overview
10.24.5 Abbvie Recent Developments
11 CONTRACEPTIVES DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptives Drugs and Devices Market Size Forecast
11.2 Global Contraceptives Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptives Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Contraceptives Drugs and Devices Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Contraceptives Drugs and Devices by Type (2026-2033)
12.1.2 Global Contraceptives Drugs and Devices Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Contraceptives Drugs and Devices by Type (2026-2033)
12.2 Global Contraceptives Drugs and Devices Market Forecast by Application (2026-2033)
12.2.1 Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Contraceptives Drugs and Devices Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Contraceptives Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptives Drugs and Devices Segment by Type
1.2.2 Contraceptives Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Contraceptives Drugs and Devices Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptives Drugs and Devices Product Life Cycle
3.3 Global Contraceptives Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptives Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptives Drugs and Devices Market Competitive Situation and Trends
3.8.1 Contraceptives Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptives Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptives Drugs and Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptives Drugs and Devices Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Contraceptives Drugs and Devices Market Size Market Share by Type (2020-2025)
6.4 Global Contraceptives Drugs and Devices Price by Type (2020-2025)
7 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Contraceptives Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVES DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Region
8.2 Global Contraceptives Drugs and Devices Market Size by Region
8.2.1 Global Contraceptives Drugs and Devices Market Size by Region
8.2.2 Global Contraceptives Drugs and Devices Market Size Market Share by Region
8.3 North America
8.3.1 North America Contraceptives Drugs and Devices Sales by Country
8.3.2 North America Contraceptives Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptives Drugs and Devices Sales by Country
8.4.2 Europe Contraceptives Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptives Drugs and Devices Sales by Region
8.5.2 Asia Pacific Contraceptives Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptives Drugs and Devices Sales by Country
8.6.2 South America Contraceptives Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Contraceptives Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVES DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives Drugs and Devices by Region(2020-2025)
9.2 Global Contraceptives Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptives Drugs and Devices Production
9.4.1 North America Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptives Drugs and Devices Production
9.5.1 Europe Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptives Drugs and Devices Production (2020-2025)
9.6.1 Japan Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptives Drugs and Devices Production (2020-2025)
9.7.1 China Contraceptives Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Basic Information
10.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
10.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Market Performance
10.1.4 Teva Pharmaceutical Industries Ltd Business Overview
10.1.5 Teva Pharmaceutical Industries Ltd SWOT Analysis
10.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.2 Church and Dwight Co. Inc
10.2.1 Church and Dwight Co. Inc Basic Information
10.2.2 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
10.2.3 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.2.4 Church and Dwight Co. Inc Business Overview
10.2.5 Church and Dwight Co. Inc SWOT Analysis
10.2.6 Church and Dwight Co. Inc Recent Developments
10.3 Reckitt Benckiser Plc
10.3.1 Reckitt Benckiser Plc Basic Information
10.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
10.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Market Performance
10.3.4 Reckitt Benckiser Plc Business Overview
10.3.5 Reckitt Benckiser Plc SWOT Analysis
10.3.6 Reckitt Benckiser Plc Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Contraceptives Drugs and Devices Product Overview
10.4.3 Pfizer Contraceptives Drugs and Devices Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Inc
10.5.1 Inc Basic Information
10.5.2 Inc Contraceptives Drugs and Devices Product Overview
10.5.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Bayer AG
10.6.1 Bayer AG Basic Information
10.6.2 Bayer AG Contraceptives Drugs and Devices Product Overview
10.6.3 Bayer AG Contraceptives Drugs and Devices Product Market Performance
10.6.4 Bayer AG Business Overview
10.6.5 Bayer AG Recent Developments
10.7 Mayer Laboratories
10.7.1 Mayer Laboratories Basic Information
10.7.2 Mayer Laboratories Contraceptives Drugs and Devices Product Overview
10.7.3 Mayer Laboratories Contraceptives Drugs and Devices Product Market Performance
10.7.4 Mayer Laboratories Business Overview
10.7.5 Mayer Laboratories Recent Developments
10.8 Inc
10.8.1 Inc Basic Information
10.8.2 Inc Contraceptives Drugs and Devices Product Overview
10.8.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.8.4 Inc Business Overview
10.8.5 Inc Recent Developments
10.9 The Female Health Company
10.9.1 The Female Health Company Basic Information
10.9.2 The Female Health Company Contraceptives Drugs and Devices Product Overview
10.9.3 The Female Health Company Contraceptives Drugs and Devices Product Market Performance
10.9.4 The Female Health Company Business Overview
10.9.5 The Female Health Company Recent Developments
10.10 Cooper Surgical
10.10.1 Cooper Surgical Basic Information
10.10.2 Cooper Surgical Contraceptives Drugs and Devices Product Overview
10.10.3 Cooper Surgical Contraceptives Drugs and Devices Product Market Performance
10.10.4 Cooper Surgical Business Overview
10.10.5 Cooper Surgical Recent Developments
10.11 Inc
10.11.1 Inc Basic Information
10.11.2 Inc Contraceptives Drugs and Devices Product Overview
10.11.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.11.4 Inc Business Overview
10.11.5 Inc Recent Developments
10.12 Allergan plc
10.12.1 Allergan plc Basic Information
10.12.2 Allergan plc Contraceptives Drugs and Devices Product Overview
10.12.3 Allergan plc Contraceptives Drugs and Devices Product Market Performance
10.12.4 Allergan plc Business Overview
10.12.5 Allergan plc Recent Developments
10.13 Cipla Limited
10.13.1 Cipla Limited Basic Information
10.13.2 Cipla Limited Contraceptives Drugs and Devices Product Overview
10.13.3 Cipla Limited Contraceptives Drugs and Devices Product Market Performance
10.13.4 Cipla Limited Business Overview
10.13.5 Cipla Limited Recent Developments
10.14 Merck and Co. Inc
10.14.1 Merck and Co. Inc Basic Information
10.14.2 Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
10.14.3 Merck and Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.14.4 Merck and Co. Inc Business Overview
10.14.5 Merck and Co. Inc Recent Developments
10.15 Veru
10.15.1 Veru Basic Information
10.15.2 Veru Contraceptives Drugs and Devices Product Overview
10.15.3 Veru Contraceptives Drugs and Devices Product Market Performance
10.15.4 Veru Business Overview
10.15.5 Veru Recent Developments
10.16 Inc
10.16.1 Inc Basic Information
10.16.2 Inc Contraceptives Drugs and Devices Product Overview
10.16.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.16.4 Inc Business Overview
10.16.5 Inc Recent Developments
10.17 Organon Group of Companies
10.17.1 Organon Group of Companies Basic Information
10.17.2 Organon Group of Companies Contraceptives Drugs and Devices Product Overview
10.17.3 Organon Group of Companies Contraceptives Drugs and Devices Product Market Performance
10.17.4 Organon Group of Companies Business Overview
10.17.5 Organon Group of Companies Recent Developments
10.18 Agile Therapeutics
10.18.1 Agile Therapeutics Basic Information
10.18.2 Agile Therapeutics Contraceptives Drugs and Devices Product Overview
10.18.3 Agile Therapeutics Contraceptives Drugs and Devices Product Market Performance
10.18.4 Agile Therapeutics Business Overview
10.18.5 Agile Therapeutics Recent Developments
10.19 TherapeuticsmMD
10.19.1 TherapeuticsmMD Basic Information
10.19.2 TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
10.19.3 TherapeuticsmMD Contraceptives Drugs and Devices Product Market Performance
10.19.4 TherapeuticsmMD Business Overview
10.19.5 TherapeuticsmMD Recent Developments
10.20 Inc
10.20.1 Inc Basic Information
10.20.2 Inc Contraceptives Drugs and Devices Product Overview
10.20.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.20.4 Inc Business Overview
10.20.5 Inc Recent Developments
10.21 Afaxys
10.21.1 Afaxys Basic Information
10.21.2 Afaxys Contraceptives Drugs and Devices Product Overview
10.21.3 Afaxys Contraceptives Drugs and Devices Product Market Performance
10.21.4 Afaxys Business Overview
10.21.5 Afaxys Recent Developments
10.22 Inc
10.22.1 Inc Basic Information
10.22.2 Inc Contraceptives Drugs and Devices Product Overview
10.22.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.22.4 Inc Business Overview
10.22.5 Inc Recent Developments
10.23 Mithra Pharmaceuticals
10.23.1 Mithra Pharmaceuticals Basic Information
10.23.2 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
10.23.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Market Performance
10.23.4 Mithra Pharmaceuticals Business Overview
10.23.5 Mithra Pharmaceuticals Recent Developments
10.24 Abbvie
10.24.1 Abbvie Basic Information
10.24.2 Abbvie Contraceptives Drugs and Devices Product Overview
10.24.3 Abbvie Contraceptives Drugs and Devices Product Market Performance
10.24.4 Abbvie Business Overview
10.24.5 Abbvie Recent Developments
11 CONTRACEPTIVES DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptives Drugs and Devices Market Size Forecast
11.2 Global Contraceptives Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptives Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Contraceptives Drugs and Devices Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Contraceptives Drugs and Devices by Type (2026-2033)
12.1.2 Global Contraceptives Drugs and Devices Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Contraceptives Drugs and Devices by Type (2026-2033)
12.2 Global Contraceptives Drugs and Devices Market Forecast by Application (2026-2033)
12.2.1 Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Contraceptives Drugs and Devices Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Contraceptives Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Contraceptives Drugs and Devices Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Contraceptives Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2024)
Table 10. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Contraceptives Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Contraceptives Drugs and Devices Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Contraceptives Drugs and Devices Sales by Type (K Units)
Table 26. Global Contraceptives Drugs and Devices Market Size by Type (M USD)
Table 27. Global Contraceptives Drugs and Devices Sales (K Units) by Type (2020-2025)
Table 28. Global Contraceptives Drugs and Devices Sales Market Share by Type (2020-2025)
Table 29. Global Contraceptives Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 30. Global Contraceptives Drugs and Devices Market Size Share by Type (2020-2025)
Table 31. Global Contraceptives Drugs and Devices Price (USD/Unit) by Type (2020-2025)
Table 32. Global Contraceptives Drugs and Devices Sales (K Units) by Application
Table 33. Global Contraceptives Drugs and Devices Market Size by Application
Table 34. Global Contraceptives Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 35. Global Contraceptives Drugs and Devices Sales Market Share by Application (2020-2025)
Table 36. Global Contraceptives Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 37. Global Contraceptives Drugs and Devices Market Share by Application (2020-2025)
Table 38. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 39. Global Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 40. Global Contraceptives Drugs and Devices Sales Market Share by Region (2020-2025)
Table 41. Global Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 42. Global Contraceptives Drugs and Devices Market Size Market Share by Region (2020-2025)
Table 43. North America Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 44. North America Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 49. South America Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 50. South America Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 53. Global Contraceptives Drugs and Devices Production (K Units) by Region(2020-2025)
Table 54. Global Contraceptives Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 56. Global Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Teva Pharmaceutical Industries Ltd Basic Information
Table 62. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
Table 63. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Teva Pharmaceutical Industries Ltd Business Overview
Table 65. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 66. Teva Pharmaceutical Industries Ltd Recent Developments
Table 67. Church and Dwight Co. Inc Basic Information
Table 68. Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
Table 69. Church and Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Church and Dwight Co. Inc Business Overview
Table 71. Church and Dwight Co. Inc SWOT Analysis
Table 72. Church and Dwight Co. Inc Recent Developments
Table 73. Reckitt Benckiser Plc Basic Information
Table 74. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
Table 75. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Reckitt Benckiser Plc Business Overview
Table 77. Reckitt Benckiser Plc SWOT Analysis
Table 78. Reckitt Benckiser Plc Recent Developments
Table 79. Pfizer Basic Information
Table 80. Pfizer Contraceptives Drugs and Devices Product Overview
Table 81. Pfizer Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Inc Basic Information
Table 85. Inc Contraceptives Drugs and Devices Product Overview
Table 86. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Inc Business Overview
Table 88. Inc Recent Developments
Table 89. Bayer AG Basic Information
Table 90. Bayer AG Contraceptives Drugs and Devices Product Overview
Table 91. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bayer AG Business Overview
Table 93. Bayer AG Recent Developments
Table 94. Mayer Laboratories Basic Information
Table 95. Mayer Laboratories Contraceptives Drugs and Devices Product Overview
Table 96. Mayer Laboratories Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Mayer Laboratories Business Overview
Table 98. Mayer Laboratories Recent Developments
Table 99. Inc Basic Information
Table 100. Inc Contraceptives Drugs and Devices Product Overview
Table 101. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Inc Business Overview
Table 103. Inc Recent Developments
Table 104. The Female Health Company Basic Information
Table 105. The Female Health Company Contraceptives Drugs and Devices Product Overview
Table 106. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. The Female Health Company Business Overview
Table 108. The Female Health Company Recent Developments
Table 109. Cooper Surgical Basic Information
Table 110. Cooper Surgical Contraceptives Drugs and Devices Product Overview
Table 111. Cooper Surgical Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Cooper Surgical Business Overview
Table 113. Cooper Surgical Recent Developments
Table 114. Inc Basic Information
Table 115. Inc Contraceptives Drugs and Devices Product Overview
Table 116. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Inc Business Overview
Table 118. Inc Recent Developments
Table 119. Allergan plc Basic Information
Table 120. Allergan plc Contraceptives Drugs and Devices Product Overview
Table 121. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Allergan plc Business Overview
Table 123. Allergan plc Recent Developments
Table 124. Cipla Limited Basic Information
Table 125. Cipla Limited Contraceptives Drugs and Devices Product Overview
Table 126. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Cipla Limited Business Overview
Table 128. Cipla Limited Recent Developments
Table 129. Merck and Co. Inc Basic Information
Table 130. Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
Table 131. Merck and Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Merck and Co. Inc Business Overview
Table 133. Merck and Co. Inc Recent Developments
Table 134. Veru Basic Information
Table 135. Veru Contraceptives Drugs and Devices Product Overview
Table 136. Veru Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Veru Business Overview
Table 138. Veru Recent Developments
Table 139. Inc Basic Information
Table 140. Inc Contraceptives Drugs and Devices Product Overview
Table 141. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Inc Business Overview
Table 143. Inc Recent Developments
Table 144. Organon Group of Companies Basic Information
Table 145. Organon Group of Companies Contraceptives Drugs and Devices Product Overview
Table 146. Organon Group of Companies Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Organon Group of Companies Business Overview
Table 148. Organon Group of Companies Recent Developments
Table 149. Agile Therapeutics Basic Information
Table 150. Agile Therapeutics Contraceptives Drugs and Devices Product Overview
Table 151. Agile Therapeutics Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Agile Therapeutics Business Overview
Table 153. Agile Therapeutics Recent Developments
Table 154. TherapeuticsmMD Basic Information
Table 155. TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
Table 156. TherapeuticsmMD Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. TherapeuticsmMD Business Overview
Table 158. TherapeuticsmMD Recent Developments
Table 159. Inc Basic Information
Table 160. Inc Contraceptives Drugs and Devices Product Overview
Table 161. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Inc Business Overview
Table 163. Inc Recent Developments
Table 164. Afaxys Basic Information
Table 165. Afaxys Contraceptives Drugs and Devices Product Overview
Table 166. Afaxys Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Afaxys Business Overview
Table 168. Afaxys Recent Developments
Table 169. Inc Basic Information
Table 170. Inc Contraceptives Drugs and Devices Product Overview
Table 171. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Inc Business Overview
Table 173. Inc Recent Developments
Table 174. Mithra Pharmaceuticals Basic Information
Table 175. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
Table 176. Mithra Pharmaceuticals Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Mithra Pharmaceuticals Business Overview
Table 178. Mithra Pharmaceuticals Recent Developments
Table 179. Abbvie Basic Information
Table 180. Abbvie Contraceptives Drugs and Devices Product Overview
Table 181. Abbvie Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Abbvie Business Overview
Table 183. Abbvie Recent Developments
Table 184. Global Contraceptives Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 185. Global Contraceptives Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 186. North America Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 187. North America Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 188. Europe Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 189. Europe Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 190. Asia Pacific Contraceptives Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 191. Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 192. South America Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 193. South America Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 194. Middle East and Africa Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (Units)
Table 195. Middle East and Africa Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 196. Global Contraceptives Drugs and Devices Sales Forecast by Type (2026-2033) & (K Units)
Table 197. Global Contraceptives Drugs and Devices Market Size Forecast by Type (2026-2033) & (M USD)
Table 198. Global Contraceptives Drugs and Devices Price Forecast by Type (2026-2033) & (USD/Unit)
Table 199. Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application (2026-2033)
Table 200. Global Contraceptives Drugs and Devices Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Contraceptives Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Contraceptives Drugs and Devices Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Contraceptives Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2024)
Table 10. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Contraceptives Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Contraceptives Drugs and Devices Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Contraceptives Drugs and Devices Sales by Type (K Units)
Table 26. Global Contraceptives Drugs and Devices Market Size by Type (M USD)
Table 27. Global Contraceptives Drugs and Devices Sales (K Units) by Type (2020-2025)
Table 28. Global Contraceptives Drugs and Devices Sales Market Share by Type (2020-2025)
Table 29. Global Contraceptives Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 30. Global Contraceptives Drugs and Devices Market Size Share by Type (2020-2025)
Table 31. Global Contraceptives Drugs and Devices Price (USD/Unit) by Type (2020-2025)
Table 32. Global Contraceptives Drugs and Devices Sales (K Units) by Application
Table 33. Global Contraceptives Drugs and Devices Market Size by Application
Table 34. Global Contraceptives Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 35. Global Contraceptives Drugs and Devices Sales Market Share by Application (2020-2025)
Table 36. Global Contraceptives Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 37. Global Contraceptives Drugs and Devices Market Share by Application (2020-2025)
Table 38. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 39. Global Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 40. Global Contraceptives Drugs and Devices Sales Market Share by Region (2020-2025)
Table 41. Global Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 42. Global Contraceptives Drugs and Devices Market Size Market Share by Region (2020-2025)
Table 43. North America Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 44. North America Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 49. South America Contraceptives Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 50. South America Contraceptives Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Contraceptives Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Contraceptives Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 53. Global Contraceptives Drugs and Devices Production (K Units) by Region(2020-2025)
Table 54. Global Contraceptives Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 56. Global Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Teva Pharmaceutical Industries Ltd Basic Information
Table 62. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
Table 63. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Teva Pharmaceutical Industries Ltd Business Overview
Table 65. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 66. Teva Pharmaceutical Industries Ltd Recent Developments
Table 67. Church and Dwight Co. Inc Basic Information
Table 68. Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
Table 69. Church and Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Church and Dwight Co. Inc Business Overview
Table 71. Church and Dwight Co. Inc SWOT Analysis
Table 72. Church and Dwight Co. Inc Recent Developments
Table 73. Reckitt Benckiser Plc Basic Information
Table 74. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
Table 75. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Reckitt Benckiser Plc Business Overview
Table 77. Reckitt Benckiser Plc SWOT Analysis
Table 78. Reckitt Benckiser Plc Recent Developments
Table 79. Pfizer Basic Information
Table 80. Pfizer Contraceptives Drugs and Devices Product Overview
Table 81. Pfizer Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Inc Basic Information
Table 85. Inc Contraceptives Drugs and Devices Product Overview
Table 86. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Inc Business Overview
Table 88. Inc Recent Developments
Table 89. Bayer AG Basic Information
Table 90. Bayer AG Contraceptives Drugs and Devices Product Overview
Table 91. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bayer AG Business Overview
Table 93. Bayer AG Recent Developments
Table 94. Mayer Laboratories Basic Information
Table 95. Mayer Laboratories Contraceptives Drugs and Devices Product Overview
Table 96. Mayer Laboratories Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Mayer Laboratories Business Overview
Table 98. Mayer Laboratories Recent Developments
Table 99. Inc Basic Information
Table 100. Inc Contraceptives Drugs and Devices Product Overview
Table 101. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Inc Business Overview
Table 103. Inc Recent Developments
Table 104. The Female Health Company Basic Information
Table 105. The Female Health Company Contraceptives Drugs and Devices Product Overview
Table 106. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. The Female Health Company Business Overview
Table 108. The Female Health Company Recent Developments
Table 109. Cooper Surgical Basic Information
Table 110. Cooper Surgical Contraceptives Drugs and Devices Product Overview
Table 111. Cooper Surgical Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Cooper Surgical Business Overview
Table 113. Cooper Surgical Recent Developments
Table 114. Inc Basic Information
Table 115. Inc Contraceptives Drugs and Devices Product Overview
Table 116. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Inc Business Overview
Table 118. Inc Recent Developments
Table 119. Allergan plc Basic Information
Table 120. Allergan plc Contraceptives Drugs and Devices Product Overview
Table 121. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Allergan plc Business Overview
Table 123. Allergan plc Recent Developments
Table 124. Cipla Limited Basic Information
Table 125. Cipla Limited Contraceptives Drugs and Devices Product Overview
Table 126. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Cipla Limited Business Overview
Table 128. Cipla Limited Recent Developments
Table 129. Merck and Co. Inc Basic Information
Table 130. Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
Table 131. Merck and Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Merck and Co. Inc Business Overview
Table 133. Merck and Co. Inc Recent Developments
Table 134. Veru Basic Information
Table 135. Veru Contraceptives Drugs and Devices Product Overview
Table 136. Veru Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Veru Business Overview
Table 138. Veru Recent Developments
Table 139. Inc Basic Information
Table 140. Inc Contraceptives Drugs and Devices Product Overview
Table 141. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Inc Business Overview
Table 143. Inc Recent Developments
Table 144. Organon Group of Companies Basic Information
Table 145. Organon Group of Companies Contraceptives Drugs and Devices Product Overview
Table 146. Organon Group of Companies Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Organon Group of Companies Business Overview
Table 148. Organon Group of Companies Recent Developments
Table 149. Agile Therapeutics Basic Information
Table 150. Agile Therapeutics Contraceptives Drugs and Devices Product Overview
Table 151. Agile Therapeutics Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Agile Therapeutics Business Overview
Table 153. Agile Therapeutics Recent Developments
Table 154. TherapeuticsmMD Basic Information
Table 155. TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
Table 156. TherapeuticsmMD Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. TherapeuticsmMD Business Overview
Table 158. TherapeuticsmMD Recent Developments
Table 159. Inc Basic Information
Table 160. Inc Contraceptives Drugs and Devices Product Overview
Table 161. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Inc Business Overview
Table 163. Inc Recent Developments
Table 164. Afaxys Basic Information
Table 165. Afaxys Contraceptives Drugs and Devices Product Overview
Table 166. Afaxys Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Afaxys Business Overview
Table 168. Afaxys Recent Developments
Table 169. Inc Basic Information
Table 170. Inc Contraceptives Drugs and Devices Product Overview
Table 171. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Inc Business Overview
Table 173. Inc Recent Developments
Table 174. Mithra Pharmaceuticals Basic Information
Table 175. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
Table 176. Mithra Pharmaceuticals Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Mithra Pharmaceuticals Business Overview
Table 178. Mithra Pharmaceuticals Recent Developments
Table 179. Abbvie Basic Information
Table 180. Abbvie Contraceptives Drugs and Devices Product Overview
Table 181. Abbvie Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Abbvie Business Overview
Table 183. Abbvie Recent Developments
Table 184. Global Contraceptives Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 185. Global Contraceptives Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 186. North America Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 187. North America Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 188. Europe Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 189. Europe Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 190. Asia Pacific Contraceptives Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 191. Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 192. South America Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 193. South America Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 194. Middle East and Africa Contraceptives Drugs and Devices Sales Forecast by Country (2026-2033) & (Units)
Table 195. Middle East and Africa Contraceptives Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 196. Global Contraceptives Drugs and Devices Sales Forecast by Type (2026-2033) & (K Units)
Table 197. Global Contraceptives Drugs and Devices Market Size Forecast by Type (2026-2033) & (M USD)
Table 198. Global Contraceptives Drugs and Devices Price Forecast by Type (2026-2033) & (USD/Unit)
Table 199. Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application (2026-2033)
Table 200. Global Contraceptives Drugs and Devices Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Contraceptives Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Drugs and Devices Market Size (M USD), 2024-2033
Figure 5. Global Contraceptives Drugs and Devices Market Size (M USD) (2020-2033)
Figure 6. Global Contraceptives Drugs and Devices Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptives Drugs and Devices Product Life Cycle
Figure 13. Contraceptives Drugs and Devices Sales Share by Manufacturers in 2024
Figure 14. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers in 2024
Figure 15. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptives Drugs and Devices Revenue in 2024
Figure 18. Industry Chain Map of Contraceptives Drugs and Devices
Figure 19. Global Contraceptives Drugs and Devices Market PEST Analysis
Figure 20. Global Contraceptives Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptives Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Contraceptives Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptives Drugs and Devices by Type in 2024
Figure 29. Market Size Share of Contraceptives Drugs and Devices by Type (2020-2025)
Figure 30. Market Size Share of Contraceptives Drugs and Devices by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptives Drugs and Devices Market Share by Application
Figure 33. Global Contraceptives Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptives Drugs and Devices Sales Market Share by Application in 2024
Figure 35. Global Contraceptives Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Contraceptives Drugs and Devices Market Share by Application in 2024
Figure 37. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptives Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptives Drugs and Devices Market Size Market Share by Region (2020-2025)
Figure 40. North America Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 45. U.S. Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptives Drugs and Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptives Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptives Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptives Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 55. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Contraceptives Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptives Drugs and Devices Market Size Market Share by Region in 2024
Figure 68. China Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 79. South America Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Contraceptives Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 82. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptives Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptives Drugs and Devices Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptives Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Contraceptives Drugs and Devices Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Contraceptives Drugs and Devices Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2026-2033)
Figure 111. Global Contraceptives Drugs and Devices Sales Forecast by Application (2026-2033)
Figure 112. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Contraceptives Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Drugs and Devices Market Size (M USD), 2024-2033
Figure 5. Global Contraceptives Drugs and Devices Market Size (M USD) (2020-2033)
Figure 6. Global Contraceptives Drugs and Devices Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptives Drugs and Devices Product Life Cycle
Figure 13. Contraceptives Drugs and Devices Sales Share by Manufacturers in 2024
Figure 14. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers in 2024
Figure 15. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptives Drugs and Devices Revenue in 2024
Figure 18. Industry Chain Map of Contraceptives Drugs and Devices
Figure 19. Global Contraceptives Drugs and Devices Market PEST Analysis
Figure 20. Global Contraceptives Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptives Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Contraceptives Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptives Drugs and Devices by Type in 2024
Figure 29. Market Size Share of Contraceptives Drugs and Devices by Type (2020-2025)
Figure 30. Market Size Share of Contraceptives Drugs and Devices by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptives Drugs and Devices Market Share by Application
Figure 33. Global Contraceptives Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptives Drugs and Devices Sales Market Share by Application in 2024
Figure 35. Global Contraceptives Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Contraceptives Drugs and Devices Market Share by Application in 2024
Figure 37. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptives Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptives Drugs and Devices Market Size Market Share by Region (2020-2025)
Figure 40. North America Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 45. U.S. Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptives Drugs and Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptives Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptives Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptives Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 55. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Contraceptives Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptives Drugs and Devices Market Size Market Share by Region in 2024
Figure 68. China Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 79. South America Contraceptives Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Contraceptives Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptives Drugs and Devices Market Size Market Share by Country in 2024
Figure 82. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptives Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptives Drugs and Devices Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Contraceptives Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptives Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Contraceptives Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Contraceptives Drugs and Devices Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Contraceptives Drugs and Devices Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2026-2033)
Figure 111. Global Contraceptives Drugs and Devices Sales Forecast by Application (2026-2033)
Figure 112. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2026-2033)
